Abstract
Neutralization of infectivity is the end result of a number of alternative or synergistic reactions between a virus and antibody directed against certain antigenic determinants on its surface. These reactions prevent either the attachment of virus to a particular host cell by steric hindrance, the entry of virus into the cell, or the uncoating of the virus particle to release the viral genome. In turn, the relative contribution of each of these to neutralization is dependent both on qualities of the viral antibodies (their relative affinities and immunoglobulin class) and specificity for relevant antigenic determinants (so-called critical sites). These considerations have been the subjects of several extensive reviews (Mandel 1979; Della-Porta and Westaway 1978).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allison LM, Salter M, Buchmeier MJ, Lewicki H, Howard CR (1984) Neutralization of arenaviruses: reaction of Tacaribe virus and variants with monoclonal antibodies. In: Compans RW, Bishop DHJL (eds) Segmented negative strand viruses. Academic, New York, pp 209–216
Barrera Oro JG, Grela ME, Zannoli VH, Garcia CA (1977) Anticuerpos contra viruses Junin y LCM en casos presuntiros de fiebre hemorragica Argentina. Medicina (B Aires) 37: 69–77
Bruns M, Cinak J, Muller G, Lehmann-Grube G (1983) Lymphocytic choriomeningitis virus. VI: Isolation of a glycoprotein mediating neutralization. Virology 130: 247–251
Buchmeier MJ (1984) Antigenic and structural studies on the glycoproteins of lymphocytic choriomeningitis virus. In: Compans RW, Bishop DHL (eds) Segmented negative strand viruses. Academic, New York, pp 193–200
Buchmeier MJ, Gee SR, Rawls WE (1977) Antigens of Pichinde virus. I: Relationship of soluble antigens derived from infected BHK-21 cells to the structural components of the virion. J Virol 22: 175–186
Buckley SM, Casals J (1970) Lassa fever, a new virus disease of man from West Africa. III: Isolation and characterization of the virus. Am J Trop Med Hyg 19: 680–691
Carballal G, Frigerio MJ (1973) Accion de los inmunosueros sobre la respuesta inmune et la fiebre hemorragica experimental. Medicina (B Aires) 23: 68–77
Chanas AC, Mann G, Young P, Ellis DS, Stamford S, Howard CR (1980) Evaluation of plaque size reduction as a method for the detection of Pichinde virus antibody. Arch Virol 65: 157– 167
Coto CE, Weissenbacher MC, Calello MA (1976) Proteccion del cabayo contra la fiebre hemorragica Argentina por innoculation de virus del complejo Tacaribe. Medicina (B Aires) 36: 9–16
Coto CE, Damonte EB, Calello MA, Weissenbacher MC (1980) Protection of guinea pigs inoculated with Tacaribe virus against lethal doses of Junin virus. J Infect Dis 141: 389–393
Coulombie FC, Damonte EB, Coto CE (1984) Influencia de la celula huesped en las reacciones de neutralizacion cruzada entre virus Junin y Tacaribe. Rev Argent Microbiol 16: 159–164
Damonte EB, Coto CE, Calello MA, Weissenbacher MC (1978) Inmunization heterologa contra virus Junin. Medicina (B Aires) 38: 226–232
Della-Porta AJ, Westaway EG (1978) A multi-hit model for the neutralization of animal viruses. J Gen Virol 38: 1–19
Eddy GA, Cole FE Jr (1978) The development of a vaccine against African hemorrhagic fever. In: Patyn SR (ed) Ebola virus haemorrhagic fever. Elsevier, Amsterdam, pp 237–242
Eddy GA, Wagner FS, Scott SK, Mahlandt BJ (1975) Protection of monkeys against Machupo virus by the passive administration of Bolivian haemorrhagic fever immunoglobulin (human origin). Bull WHO 52:723–727
Enria DA, Briggiler AM, Fernandez NJ, Levis SC, Maiztegui JI (1984) Importance of dose of neutralizing antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet II:255–256
Fazekas de St Groth S (1962) The neutralization of viruses. Adv Virus Res 9: 1–125
Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM (1970) Lassa fever, a new virus disease of man from West Africa. I: Clinical description and pathological findings. Am J Trop Med Hyg 19: 670–676
Henderson JR, Downs WG (1965) Junin and Tacaribe plaque reduction in rhesus monkey kidney cell monolayers. Am J Trop Med Hyg 14: 796–797
Hotchin J (1962) The biology of lymphocytic choriomeningitis infection: virus induced immune disease. Cold Spring Harbour Symp Quant Biol 27:479–499
Hotchin J, Kinch W (1975) Microplaque reduction: new assay for neutralizing antibody to lymphocytic choriomeningitis virus. J Infect Dis 131: 186–188
Howard CR, Lewicki H, Allison L, Salter M, Buchmeier MJ (1985) Properties and characterization of monoclonal antibodies to Tacaribe virus. J Gen Virol 66: 1383–1395
Iorio RM, Bratt M (1984) Neutralization of Newcastle disease virus by monoclonal antibodies to haemagglutinin neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. J Virol 51: 445–451
Jahrling PB (1983) Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate and human origin. J Med Virol 12: 93–102
Jahrling PB, Peters CJ (1984) Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect Immun 44: 528–533
Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL (1980) Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis 141: 580–589
Jahrling PB, Smith S, Hesse RA, Rhoderick JB (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun 37: 771–778
Johnson KM, Webb PA, Justines G (1973) Biology of Tacaribe-complex viruses. In: Lehmann-Grube F (ed) Lymphocytic choriomeningitis virus and other arenaviruses. Springer, Berlin Heidelberg New York, pp 241–258
Lehmann-Grube F (1971) Lymphocytic choriomeningitis virus. Virology monographs, vol 10. Springer, Berlin Heidelberg New York
Lehmann-Grube F, Kallay M, Ibscher B, Schwartz R (1979) Serologic diagnosis of human infections with lymphocytic choriomeningitis virus: comparative evaluation of seven methods. J Med Virol 4: 125–136
Leifer E, Gocke DJ, Bourne H (1970) Lassa fever, a new virus disease of man from West Africa. II: Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 19: 677–679
Levis SC, Saavedra MC, Ceccoli C, Falcoff E, Feuillade MR, Enria DAM, Maiztegui JI, Falcoff R (1984) Endogenous interferon in Argentine haemorrhagic fever. J Infect Dis 149: 428–433
Maiztegui JI, Sabattini MS, Barrera Oro JG (1972) Actividad del virus de la coriomeningitis linfocitica (LCM) en el area endemica de fiebre hemorragica Argentina (FHA). I: Estudios serologicos en rodeores capturados en la ciudad de pergamino. Medicina (B Aires) 32: 131–137
Maiztegui JI, Fernandez NJ, de Damilano AJ (1979) Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet II: 1216–1217
Mandel B (1979) Interactions of viruses with neutralizing antibodies. In: Fraenkel-Conrat H, Wagner RR (eds) Comprehensive virology, vol 15. Plenum, New York, pp 37–121
Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A (1974) Lassa fever in the eastern province of Sierra Leone, 1970–1972. II: Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 23: 1140–1149
Sabattini MS, Barrera Oro JG, Maiztegui JI, Ferradas BR de (1974) Actividad del virus de la coriomeningitis linfocitica en el area endemica de fiebre hemorragica Argentina. II: Aislamiento a partir de un Mus musculus campestre capuado en el sudeste de Cordoba. Medicina (B Aires) 34:313
Sengupta S, Rawls WE (1979) Pseudotypes of vesicular stromatitis virus and Pichinde virus. J Gen Virol 42: 141–148
Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24: 40–69
Tauraso NM, Shelokov A (1965) Protection against Junin virus by immunization with live Tacaribe virus. Proc Soc Exp Biol Med 119: 608–611
Teyssie AR, Gutman Frugone LF, Ayerra de Holstein B, Barrera Oro JG (1971) Nivel de anticuerpos contra virus Junin en un grupo de personal de laboratorio. Medicina (B Aires) 31: 113–116
Volk WA, Snyder RM, Benjamin DC, Wagner RR (1982) Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol 42: 220–227
Webb PA, Johnson KM, MacKenzie RB (1969) The measurement of specific antibodies in Bolivian haemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med 130: 1013–1019
Weissenbacher MC, Coto CE, Calello MA (1975/1976) Cross-protection between Tacaribe complex viruses. Protection of neutralizing antibodies against Junín virus (Argentine hemorrhagic fever) in guinea pigs infected with Tacaribe virus. Intervirology 6: 42–49
Weissenbacher MC, Edelmuth E, Firgerio MJ, Coto CE, de Guerrero LB (1980) Serological survey to detect subclinical Junín virus infection in laboratory personnel. J Med Virol 6: 223–226
Weissenbacher MC, Coto CE, Calello MA, Rondinone SN, Damonte EB, Frigerio MJ (1982) Cross-protection in non-human primates against Argentine hemorrhagic fever. Infect Immun 35:425–430
Wulff H, Lange JV (1975) Indirect immunofluorescence for the diagnosis of Lassa fever infections. Bull WHO 52:429–436
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Howard, C.R. (1987). Neutralization of Arenaviruses by Antibody. In: Oldstone, M.B.A. (eds) Arenaviruses. Current Topics in Microbiology and Immunology, vol 134. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71726-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-71726-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71728-4
Online ISBN: 978-3-642-71726-0
eBook Packages: Springer Book Archive